Navigation Links
Force FX Electrosurgical Generator

ProductsForce FX Electrosurgical Generator
Company Valleylab
Item Force FX Electrosurgical Generator
Features Valleylab introduces the Force FX generator which uses Instant Response Technology - to ensure consistant clinical performance using less power. Improved performance at lower voltages reduces sparking, thermal spread, neuro-muscular stimulation and RF interference. Cutting, coagulating and bipolar outputs are designed for laparoscopic surgery. Low cut and Low coag outputs use lower voltages to reduce the risks of electrosurgery. Macrobipolar mode is designed specifically for today's new generation of macrobipolar cutting instruments. Valleylab REM Safety virtually eliminates the risk of patient burns at the return electrode site. Three bipolar modes: low/precise, medium/standard, and macrobipolar are also controlled by the Instant Response system. Low and medium settings utilize low voltage to prevent sparking. CEM mode allows the Force FX generator to be used with the CUSA CEM nosecone.
Description Microcontroller-based isolated electrosurgical generator, designed for all general purpose surgical procedures. Unit includes: Instant Response technology, adaptive REM system, isolated output, CEM compatible, bipolar current monitor compatible.
Info Valleylab
Customer Service: (800) 255-8522
Web site: http://www.valleylab.com/

Related medicine products :

1. Ostrum Antrum Punch Forceps
2. Storz Antrum Punch Forceps
3. Sidebiting Antrum Punch Forceps
4. Pediatric Ostrum Antrum Punch Forceps
5. Rotating Ostrum Antrum Punch Forceps
6. Pediatric Rotating Ostrum Antrum Punch Forceps
7. Force EZ Electrosurgical Generator
8. Force Generator
9. Force 1C Generator
10. Force 2 Generator
11. McPherson Straight Bipolar Forceps
Breaking Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Glens Markets Adds Discounted Generic Drug Program 49508 1Glens Markets Adds Discounted Generic Drug Program 49508 2Glens Markets Adds Discounted Generic Drug Program 49508 3Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 49504 1Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 49504 2Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 49504 3Bicycle Helmet Laws For Kids Effective But Not Yet the Norm 49504 4Brain Imaging Study Sheds Light on Fibromyalgia 49502 1